Results

Amgen Inc.

09/24/2021 | Press release | Distributed by Public on 09/24/2021 18:16

FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia